Crossmark

A comparative study of the cardioprotective effect of Metformin, Sitagliptin and Dapagliflozin on Isoprenaline induced myocardial infarction in non-diabetic rats

Crossref DOI link: https://doi.org/10.1186/s42269-022-00812-1

Published Online: 2022-04-25

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ibrahim, Mostafa Mahmoud

Khedr, Mohamed Mostafa

Morsy, Manal Hamza

Badae, Noha Mohamed

Elatrebi, Soha http://orcid.org/0000-0002-1111-7779
License Information

Text and Data Mining valid from 2022-04-25

Version of Record valid from 2022-04-25
More Information

Article History

Received: 14 March 2022

Accepted: 12 April 2022

First Online: 25 April 2022

Declarations

:

: This an experimental animal study. All experimental procedures were approved and performed in compliance with the guidelines of the Local Ethics Committee of Alexandria Faculty of Medicine, University of Alexandria (IRB code 00012098-FWA: No. 00018699; membership in International Council of Laboratory Animal science organization ICLAS). All experimental procedures were strictly carried out following the ethical guidelines.

: Not applicable.

: The authors declare they have no competing interests.

Document is current

Any future updates will be listed below